ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
How to invest
How to turn $20,000 into over $250,000 in 10 years with ASX shares
Healthcare Shares
The ResMed (ASX:RMD) share price is up 25% in 2020
Healthcare Shares
These are 8 of the best performing ASX healthcare shares of 2020 so far
Growth Shares
5 ASX shares rated as buys by top fundie
Share Market News
ASX stock of the day: Immutep (ASX:IMM) shares blast up 60% on trial news
⏸️ ASX Shares
2 fantastic ASX healthcare shares to buy for 2021
Growth Shares
3 stellar ASX growth shares to buy
Growth Shares
3 ASX growth shares to buy for 2021
⏸️ ASX Shares
10 fantastic ASX shares to buy in December
Growth Shares
2 top ASX healthcare shares that could be market beaters
Growth Shares
Where you could invest $20,000 into ASX shares today
52-Week Highs
Why ResMed (ASX:RMD) and these ASX shares just hit record highs
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
